热门资讯> 正文
Nuwellis获得USPTO双腔导管专利批准
2026-04-28 22:05
- Nuwellis (NUWE) announced on Tuesday that it received a Notice of Allowance from the USPTO for a new patent on its dual-lumen catheter used in ultrafiltration therapy, aimed at improving blood flow and reducing treatment complications.
- The catheter comes with an adjustable, flexible design that doctors can customize during treatment, ensuring smoother usage and consistent performance across patients.
- Once the patent is officially approved, it is expected to strengthen Nuwellis’ (NUWE) product lineup and support the expansion of ultrafiltration therapy in hospitals and outpatient settings.
- The stock is trading ~3% lower at ~$1.13.
- Source: Press Release
More on Nuwellis
- Nuwellis, Inc. (NUWE) Q4 2025 Earnings Call Transcript
- Quant snapshot: Avino Silver & Gold, Harmony Gold lead strong buys as Angel Studios, Exagen lag
- Nuwellis to acquire Rendiatech, raises $5 mln in private placement
- Seeking Alpha’s Quant Rating on Nuwellis
- Historical earnings data for Nuwellis
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。